Cytosorbents (CTSO) Non Operating Income (2016 - 2025)
Historic Non Operating Income for Cytosorbents (CTSO) over the last 15 years, with Q3 2025 value amounting to -$709000.0.
- Cytosorbents' Non Operating Income fell 13438.41% to -$709000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 3330.58%. This contributed to the annual value of -$5.6 million for FY2024, which is 39785.4% down from last year.
- Latest data reveals that Cytosorbents reported Non Operating Income of -$709000.0 as of Q3 2025, which was down 13438.41% from $5.6 million recorded in Q2 2025.
- Cytosorbents' Non Operating Income's 5-year high stood at $5.6 million during Q2 2025, with a 5-year trough of -$5.5 million in Q4 2024.
- In the last 5 years, Cytosorbents' Non Operating Income had a median value of -$709000.0 in 2025 and averaged -$77537.3.
- Examining YoY changes over the last 5 years, Cytosorbents' Non Operating Income showed a top increase of 103468.41% in 2022 and a maximum decrease of 112028.37% in 2022.
- Over the past 5 years, Cytosorbents' Non Operating Income (Quarter) stood at -$481194.0 in 2021, then surged by 1034.68% to $4.5 million in 2022, then plummeted by 40.13% to $2.7 million in 2023, then crashed by 305.32% to -$5.5 million in 2024, then soared by 87.18% to -$709000.0 in 2025.
- Its Non Operating Income stands at -$709000.0 for Q3 2025, versus $5.6 million for Q2 2025 and $2.4 million for Q1 2025.